News

Hold the immunomodulators for surgery? Maybe yes, maybe no


 

AT THE PERIOPERATIVE MEDICINE SUMMIT

There is conflicting information on infection risk with the use leflunomide (Arava), but it may be wise to stop therapy 2-4 weeks before nonurgent surgery in higher-risk patients.

There is consensus that sulfasalazine (Azulfidine) and azathioprine (Imuran) can be safely continued perioperatively, he said, although some advise holding sulfasalazine on the day of surgery.

Regarding perioperative steroids, Dr. Grant recommended determining the patient’s steroid exposure over the past year.

"Stress dose steroids are not routinely needed as long as the patients continue their normal dose. That’s really the important piece: If someone’s taking prednisone every day, make sure they take at least that dose on the day of surgery," he said.

Dr. Grant reported having no financial disclosures.

Pages

Recommended Reading

Consider rituximab when RA patients fail their first TNF inhibitor
MDedge Rheumatology
Skin cancer risk stands out in anti-TNF biologics use
MDedge Rheumatology
New quality indicator for rheumatologists: vaccination rates
MDedge Rheumatology
Shift in approach needed for managing inflammatory arthritis in pregnancy
MDedge Rheumatology
No new cardiovascular warnings needed for NSAIDs say FDA advisers
MDedge Rheumatology
NIH and pharma partner on RA, lupus, diabetes, Alzheimer’s research
MDedge Rheumatology
Monoclonal antibody against new target found safe for moderate RA
MDedge Rheumatology
TNF inhibitors reduce coronary artery disease risk in rheumatoid arthritis
MDedge Rheumatology
Arthroplasty for rheumatoid arthritis doesn’t boost cardiovascular risk
MDedge Rheumatology
Methotrexate alone or with etanercept have equal efficacy for early inflammatory arthritis
MDedge Rheumatology

Related Articles